CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 106 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,415,629 | -11.6% | 292,186 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $3,864,833 | +82925.4% | 287,562 | +2.4% | 0.00% | -33.3% |
| Q1 2023 | $4,655 | -5.3% | 280,781 | +6.2% | 0.01% | -14.3% |
| Q4 2022 | $4,917 | -99.9% | 264,341 | +2.3% | 0.01% | +40.0% |
| Q3 2022 | $3,314,000 | +326.5% | 258,301 | +133.2% | 0.01% | +400.0% |
| Q2 2022 | $777,000 | -26.8% | 110,784 | -13.4% | 0.00% | 0.0% |
| Q1 2022 | $1,061,000 | +5.6% | 127,953 | -13.8% | 0.00% | 0.0% |
| Q4 2021 | $1,005,000 | +26.7% | 148,483 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $793,000 | -6.4% | 149,572 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $847,000 | +53.7% | 147,391 | +23.3% | 0.00% | 0.0% |
| Q1 2021 | $551,000 | +30.6% | 119,546 | -5.3% | 0.00% | 0.0% |
| Q4 2020 | $422,000 | +19.2% | 126,286 | +6.0% | 0.00% | 0.0% |
| Q3 2020 | $354,000 | -43.6% | 119,156 | -12.4% | 0.00% | 0.0% |
| Q2 2020 | $628,000 | +29.2% | 135,961 | +7.7% | 0.00% | 0.0% |
| Q1 2020 | $486,000 | +2.7% | 126,260 | +0.1% | 0.00% | 0.0% |
| Q4 2019 | $473,000 | -29.0% | 126,145 | +0.6% | 0.00% | 0.0% |
| Q3 2019 | $666,000 | +37.3% | 125,392 | -0.6% | 0.00% | 0.0% |
| Q2 2019 | $485,000 | -22.9% | 126,182 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $629,000 | +158.8% | 123,245 | -2.7% | 0.00% | 0.0% |
| Q4 2018 | $243,000 | -23.8% | 126,699 | +49.9% | 0.00% | 0.0% |
| Q3 2018 | $319,000 | +12.7% | 84,500 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $283,000 | +75.8% | 90,725 | +34.7% | 0.00% | – |
| Q1 2018 | $161,000 | -34.0% | 67,342 | +7.7% | 0.00% | – |
| Q4 2017 | $244,000 | +25.8% | 62,517 | -18.6% | 0.00% | – |
| Q3 2017 | $194,000 | -7.2% | 76,796 | +1.4% | 0.00% | – |
| Q2 2017 | $209,000 | +132.2% | 75,701 | -1.2% | 0.00% | – |
| Q1 2016 | $90,000 | -51.1% | 76,641 | +1.9% | 0.00% | -100.0% |
| Q4 2015 | $184,000 | -10.7% | 75,216 | +9.8% | 0.00% | 0.0% |
| Q3 2015 | $206,000 | -22.8% | 68,506 | +5.8% | 0.00% | 0.0% |
| Q2 2015 | $267,000 | – | 64,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |